Umlobi: Gregory Harris
Usuku Lokudalwa: 10 Epreli 2021
Ukuvuselela Usuku: 26 Ujuni 2024
Anonim
Organic Guaraná in Brazil: Indigenous peoples show the way | Global Ideas
Ividiyo: Organic Guaraná in Brazil: Indigenous peoples show the way | Global Ideas

-Delile

IGuarana isitshalo. Ibizwa ngesizwe samaGuarani e-Amazon, esisebenzise imbewu yaso ukwenza isiphuzo. Namuhla, imbewu ye-guarana isasetshenziswa njengomuthi.

Abantu bathatha i-guarana ngomlomo ukukhuluphala, ukusebenza kwezemidlalo, ukusebenza kwengqondo, ukukhulisa amandla, njenge-aphrodisiac, nezinye izimo eziningi, kepha abukho ubufakazi obuhle besayensi bokusekela lokhu kusetshenziswa. IGuarana nayo ingaphepha uma ithathwa isikhathi eside ngamanani amakhulu.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze IGUARANA zimi kanje:

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Ukukhathazeka. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha umkhiqizo oqukethe i-hawthorn, i-black horehound, i-passionflower, i-valerian, i-cola nut, ne-guarana kunganciphisa ukukhathazeka kwabanye abantu. Akucaci ukuthi i-guarana iyodwa iyazuzisa yini.
  • Ukungabi nesifiso kubantu abanomdlavuza. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-guarana kukhipha kancane kuthuthukisa isifiso sokudla futhi kuvimbele ukwehla kwesisindo kubantu abanomdlavuza abaphelelwe yisifiso sabo futhi abancipha emzimbeni. Kepha inzuzo incane kakhulu.
  • Ukukhathala kwabantu abaphathwa ngemithi yomdlavuza. Olunye ucwaningo lubonisa ukuthi ukuthatha i-guarana kunganciphisa imizwa yokukhathala kwabanye abantu abelashwa ngamakhemikhali. Kepha kunemiphumela ephikisanayo.
  • Ukwenza ngcono inkumbulo namakhono okucabanga (umsebenzi wokuqonda). Ukucwaninga kwasekuqaleni kubantu abaphilile kukhombisa ukuthi ukuthatha umthamo owodwa wokukhishwa kwe-guarana kungathuthukisa isivinini sokucabanga nezinye izici zememori. Kodwa-ke, olunye ucwaningo lubonisa ukuthi ukuthatha i-guarana akukuthuthukisi ukusebenza kwengqondo kubantu abadala noma kubantu abadala.
  • Ukusebenza kwezemidlalo. Ucwaningo lukhombisa ukuthi ukuthatha umthamo owodwa womkhiqizo oqukethe i-guarana, amavithamini B, uvithamini C, namaminerali kuthuthukisa ukubekezelelana kokuzivocavoca kubasubathi abaqeqeshiwe ngemali encane kakhulu. Akucaci ukuthi i-guarana iyodwa iyazuzisa yini.
  • Ukukhuluphala ngokweqile. Ukuthatha i-guarana kanye ne-mate ne-damiana kubonakala kukhulisa ukuncipha. Kukhona nobufakazi obukhulayo bokuthi ukuthatha umkhiqizo othile wokuhlanganiswa oqukethe i-guarana, i-ephedra, namanye amavithamini ayi-17, amaminerali, kanye nezithako kusiza ekwehliseni isisindo cishe ngama-2.7 kg kumaviki ayisishiyagalombili lapho kusetshenziswa ukudla okunamafutha amancane nokuvivinya umzimba. Akucaci ukuthi i-guarana iyodwa iyazuzisa yini.
  • Imizwa yenhlalakahle. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-guarana akuyithuthukisi imizwa yenhlalakahle kubantu abaphilile.
  • Ukugula okubucayi okubangelwa ukuvezwa yimisebe. Ucwaningo lukhombisa ukuthi ukuthatha i-guarana akuzithuthukisi izimpawu zokucindezeleka noma ukukhathala kubantu abelashwa ngemisebe.
  • Ukusebenza kwezemidlalo.
  • Isifo sokukhathala okungamahlalakhona (CFS).
  • Uhudo.
  • Ukungasebenzi kwe-Erectile (ED).
  • Ukukhathala.
  • Imfiva.
  • Ukugcinwa kwamanzi.
  • Ubuhlungu bekhanda.
  • Isifo senhliziyo.
  • Ukwandisa isifiso sobulili kubantu abaphilile.
  • Umfutho wegazi ophansi.
  • Umalaleveva.
  • Izikhukhula zokuya esikhathini (i-dysmenorrhea).
  • Isifo samathambo (RA).
  • Ezinye izimo.
Kudingeka ubufakazi obengeziwe ukukala ukusebenza kwe-guarana kulokhu kusetshenziswa.

IGuarana iqukethe i-caffeine. I-caffeine isebenza ngokuvuselela uhlelo oluphakathi lwezinzwa (CNS), inhliziyo, nemisipha. IGuarana iqukethe i-theophylline ne-theobromine, okungamakhemikhali afana ne-caffeine.

Lapho ithathwa ngomlomo: UGuarana unjalo CISHE UVIKILE kubantu abadala abaningi uma bethathwa ngamanani atholakala kakhulu ekudleni. Lapho iphuzwa ngomlomo ngamanani okwelapha isikhashana, i-guarana OKUNGENZEKA UKUPHEPHA.

Lapho iphuzwa ngomlomo ngemithamo ephezulu isikhathi eside, i-guarana MHLAWUMBI ANGIPHEPHILE. IGuarana iqukethe i-caffeine. Imithamo equkethe ngaphezu kuka-400 mg we-caffeine nsuku zonke ixhunyaniswe nemiphumela emibi. Imiphumela emibi incike kumthamo. Emithamo ejwayelekile, i-caffeine ese-guarana ingadala ukuqwasha, uvalo nokungazinzi, ukucasuka esiswini, isicanucanu, ukuhlanza, ukukhuphuka kwenhliziyo nomfutho wegazi, ukuphefumula ngokushesha, ukundindizela, i-delirium, i-diuresis, neminye imiphumela emibi. Imithamo emikhulu ye-guarana ingadala ikhanda, ukukhathazeka, ukuyaluza, ukukhala ezindlebeni, ubuhlungu lapho uchama, ukuqunjelwa yisisu, nokushaya kwenhliziyo okungajwayelekile. Abantu abathatha i-guarana njalo bangathola izimpawu zokuhoxa kwe-caffeine uma behlisa umthamo wabo ojwayelekile.

Lapho iphuzwa ngomlomo noma ijojowe ngemithamo ephezulu kakhulu, i-guarana Cishe UNGAPHEPHILE futhi okubulalayo, ngenxa yokuqukethwe yi-caffeine. Umthamo obulalayo we-caffeine ulinganiselwa kuma-10-14 amagremu. Ubuthi obuyingozi bungabuye bube khona ngemithamo ephansi, kuya ngokuzwela komuntu nge-caffeine noma ngokuziphatha kokubhema, ubudala, nokusetshenziswa kwangaphambili kwe-caffeine.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: UGuarana unjalo OKUNGENZEKA UKUPHEPHA kwabesifazane abakhulelwe nabancelisayo lapho bethathwe ngamanani atholakala kakhulu ekudleni. Uma ukhulelwe noma uncelisa ibele, i-guarana kufanele ithathwe ngokuqapha ngenxa yokuqukethwe yi-caffeine. Amanani amancane mhlawumbe awalimazi. Kodwa-ke, ukuthatha i-guarana ngemithamo ephezulu ngomlomo MHLAWUMBI ANGIPHEPHILE. Ukudla okungaphezu kwama-300 mg we-caffeine nsuku zonke kuye kwaxhunyaniswa nengozi eyengeziwe yokukhulelwa kwesisu neminye imiphumela emibi.

Kwabesifazane abahlengikazi, i-caffeine idlulela ebisini lwebele futhi ingathinta usana olusancelayo. Omama abahlengikazi kufanele baqaphe ngokucophelela ukudla kwe-caffeine ukuze kuqinisekiswe ukuthi kusezansi. Ukudla okuphezulu kwe-caffeine ngomama abahlengikazi kungadala izinkinga zokulala, ukucasuka, kanye nokwanda kwamathumbu ezinganeni ezisanceliswa.

Ukukhathazeka: I-caffeine ese-guarana ingenza imizwa yokukhathazeka ibe yimbi kakhulu.

Izinkinga zokopha: Kunobunye ubufakazi obuphakamisa ukuthi i-caffeine ese-guarana ingenza ukuphazamiseka kokopha kube kubi kakhulu, yize lokhu kungabikwanga kubantu. Uma unenkinga yokopha, hlola umhlinzeki wakho wezokunakekelwa kwempilo ngaphambi kokuqala i-guarana.

Isifo sikashukela: Olunye ucwaningo lubonisa ukuthi i-caffeine ese-guarana ingathinta indlela abantu abanesifo sikashukela abasebenza ngayo ushukela (i-glucose) futhi ingahle ibe nzima ukulawula ushukela egazini. Kukhona nolunye ucwaningo oluthokozisayo olukhombisa ukuthi i-caffeine ingahle ithuthukise izimpawu zokuxwayisa ngoshukela ophansi wegazi ezigulini ezinesifo sikashukela sohlobo 1. Olunye ucwaningo lukhombisa ukuthi izimpawu zikashukela wegazi ziphansi kakhulu uma ziqala lapho kungekho i-caffeine, kepha njengoba ushukela ophansi wegazi uqhubeka, izimpawu zikhulu nge-caffeine. Lokhu kungakhuphula ikhono leziguli ezinesifo sikashukela lokuthola nokwelapha ushukela wegazi ophansi. Kodwa-ke, okubi ukuthi i-caffeine ingase ikhulise inani leziqephu ezinoshukela ophansi. Uma unesifo sikashukela, khuluma nomhlinzeki wakho wezokunakekelwa kwempilo ngaphambi kokuqala i-guarana.

Uhudo. IGuarana iqukethe i-caffeine. I-caffeine ese-guarana, ikakhulukazi uma iphuzwa kakhulu, ingalwenza lube muncu uhudo.

Ukuquleka. IGuarana iqukethe i-caffeine. I-caffeine ese-guarana ingakhuphula ubungozi bokuquleka futhi inciphise izinzuzo zemithi eminingi esetshenziselwa ukulawula ukuquleka. Uma unesithuthwane, khuluma nomhlinzeki wakho wezokunakekelwa kwempilo ngaphambi kokusebenzisa i-guarana.

I-irritable bowel syndrome (IBS): IGuarana iqukethe i-caffeine. I-caffeine ese-guarana, ikakhulukazi uma ithathwa kakhulu, ingalwenza lubi kakhulu uhudo futhi ingase isibhebhethekise nohudo abanye abantu abanalo ne-IBS.

Isifo senhliziyo: I-caffeine ese-guarana ingadala ukushaya kwenhliziyo okungajwayelekile kubantu abathile. Sebenzisa ngokuqapha.

Umfutho wegazi ophezulu: Ukuthatha i-guarana kungakhuphula umfutho wegazi, kubantu abane-high blood pressure ngenxa yokuqukethwe yi-caffeine. Kodwa-ke, lo mphumela ungahle ube mncane kubantu abaphuza njalo ikhofi noma basebenzise i-caffeine njalo.

I-Glaucoma: I-caffeine ese-guarana yandisa ingcindezi ngaphakathi kweso. Ukwanda kwenzeka ngaphakathi kwemizuzu engama-30 futhi kuhlala okungenani imizuzu engama-90 ngemuva kokuphuza iziphuzo ezine-caffeine.

Izinkinga zokulawula isinye (Incontinence): IGuarana iqukethe i-caffeine. I-caffeine ese-guarana inganciphisa ukulawula isinye, ikakhulukazi kwabesifazane asebekhulile. Uma udinga ukuchama kaningi ngokuphuthuma okukhulu, sebenzisa i-guarana ngokuqapha.

I-osteoporosis: I-caffeine ese-guarana ingakhipha i-calcium emzimbeni ngezinso. Lokhu kulahleka kwe-calcium kunganciphisa amathambo. Uma une-osteoporosis, ungadli ngaphezu kuka-300 mg we-caffeine ngosuku. Ukuthatha izithako ze-calcium kungasiza futhi ukufaka enye i-calcium elahlekile. Uma uvame ukuba nempilo enhle futhi uthola i-calcium eyanele ekudleni kwakho noma kokunezelayo, ukuthatha kuze kufike ku-400 mg we-caffeine ngosuku akubonakali kwandisa ubungozi bokuthola i-osteoporosis.

Ischizophrenia: IGuarana iqukethe i-caffeine. I-caffeine ese-guarana ingenza ezinye izimpawu ze-schizophrenia zibe zimbi kakhulu. Uma une-schizophrenia, sebenzisa i-guarana ngokuqapha.

Okukhulu
Ungathathi le nhlanganisela.
Ama-Amphetamines
Izidakamizwa ezikhuthazayo ezifana nama-amphetamine zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi ikhuphule izinga lokushaya kwenhliziyo yakho. I-caffeine ese-guarana nayo ingasheshisa isimiso sezinzwa. Ukuthatha i-guarana kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kufaka phakathi ukukhuphuka kwenhliziyo nomfutho wegazi ophakeme. Gwema ukuthatha izidakamizwa ezakhayo kanye ne-caffeine.
Cocaine
Izidakamizwa ezikhuthazayo ezifana ne-cocaine zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi ikhuphule izinga lokushaya kwenhliziyo yakho. I-caffeine ese-guarana nayo ingasheshisa isimiso sezinzwa. Ukuthatha i-guarana kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kubandakanya ukukhuphuka kwenhliziyo nomfutho wegazi ophakeme. Gwema ukuthatha izidakamizwa ezakhayo kanye ne-caffeine.
Ephedrine
Izidakamizwa ezikhuthazayo zisheshisa isimiso sezinzwa. I-caffeine (equkethwe ku-guarana) ne-ephedrine yomibili imishanguzo evuselelayo. Ukuthatha i-guarana kanye ne-ephedrine kungadala ukukhuthazeka kakhulu futhi kwesinye isikhathi kube nemiphumela emibi kakhulu nezinkinga zenhliziyo. Ungathathi imikhiqizo equkethe i-caffeine kanye ne-ephedrine ngasikhathi sinye.
Maphakathi
Qaphela ngale nhlanganisela.
I-Adenosine (Adenocard)
IGuarana iqukethe i-caffeine. I-caffeine ese-guarana ingavimba ukuthinteka kwe-adenosine (Adenocard). I-Adenosine (i-Adenocard) ivame ukusetshenziswa odokotela ukwenza ukuhlolwa enhliziyweni. Lokhu kuhlolwa kubizwa ngokuthi yi-cardiac test test. Yeka ukusebenzisa i-guarana noma eminye imikhiqizo equkethe i-caffeine okungenani amahora angama-24 ngaphambi kokuhlolwa kwengcindezi yenhliziyo.
I-Carbamazepine (Tegretol)
ICarbamazepine (Tegretol) isetshenziselwa ukwelapha ukuquleka okuthile. I-caffeine e-guarana ingehlisa imiphumela ye-carbamazepine (Tegretol) noma inyuse indlela umuntu athinteka ngayo ekuqulekeni. Ngokwethiyori, ukuthatha i-guarana ne-carbamazepine (Tegretol) kunganciphisa imiphumela yayo futhi kukhuphule ubungozi bokuquleka kwabanye abantu.
I-Cimetidine (Tagamet)
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Cimetidine (Tagamet) inganciphisa ukuthi umzimba wakho wephula ngokushesha kanjani i-caffeine. Ukuthatha i-cimetidine (Tagamet) kanye ne-guarana kungakhuphula amathuba okuba nemiphumela engemihle ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu, ukushaya kwenhliziyo okusheshayo, nokunye.
I-Clozapine (Clozaril)
Umzimba wephula i-clozapine (i-Clozaril) ukuze uyiqede. I-caffeine ese-guarana ibonakala incipha ukuthi umzimba weqa kanjani i-clozapine (Clozaril) ngokushesha. Ukuthatha i-guarana kanye ne-clozapine (i-Clozaril) kungakhuphula imiphumela kanye nemiphumela emibi ye-clozapine (Clozaril).
I-Dipyridamole (Persantine)
IGuarana iqukethe i-caffeine. I-caffeine ese-guarana ingavimba imiphumela ye-dipyridamole (Persantine). IDipyridamole (Persantine) ivame ukusetshenziswa odokotela ukwenza ukuhlolwa enhliziyweni. Lokhu kuhlolwa kubizwa ngokuthi yi-cardiac test test. Yeka ukusebenzisa i-guarana noma eminye imikhiqizo equkethe i-caffeine okungenani amahora angama-24 ngaphambi kokuhlolwa kwengcindezi yenhliziyo.
I-Disulfiram (Antabuse)
Umzimba wephula i-caffeine ukuze uyiqede. I-Disulfiram (Antabuse) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha okukhulu. Ukuthatha i-guarana (equkethe i-caffeine) kanye ne-disulfiram (i-Antabuse) kungakhuphula imiphumela kanye nemiphumela emibi ye-caffeine kufaka phakathi i-jitteriness, hyperactivity, irritability, nokunye.
Ama-Estrogens
Umzimba wephula i-caffeine ese-guarana ukuze uyiqede. Ama-Estrogens anganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukuthatha i-guarana kanye ne-estrogens kungadala ukuqina, ikhanda, ukushaya kwenhliziyo okusheshayo, neminye imiphumela emibi. Uma uthatha ama-estrogens, nciphisa umthamo wakho we-caffeine.

Amanye amaphilisi e-estrogen afaka phakathi ama-equine estrogens ahlanganisiwe (Premarin), i-ethinyl estradiol, i-estradiol namanye.
I-Ethosuximide
I-Ethnosuximide isetshenziselwa ukulawula izinhlobo ezithile zokubanjwa. I-caffeine e-guarana ingahle yehlise imiphumela ye-ethnosuximide noma inyuse ukuthi umuntu uthinteka kalula kanjani ekuqulekeni. Ngokwethiyori, ukuthatha i-guarana nge-ethnosuximide kunganciphisa imiphumela yayo futhi kwandise ingozi yokuquleka.
I-Felbamate
I-Felbamate isetshenziselwa ukulawula izinhlobo ezithile zokubanjwa. I-caffeine e-guarana inganciphisa imiphumela ye-felbamate noma inyuse indlela umuntu athinteka ngayo ekuqulekeni. Ngokwethiyori, ukuthatha i-guarana nge-felbamate kunganciphisa imiphumela yayo futhi kwandise ingozi yokuquleka.
I-Flutamide (Eulexin)
Umzimba wephula i-flutamide (i-Eulexin) ukuze uyiqede. I-caffeine e-guarana inganciphisa ukuthi umzimba wephula kanjani i-flutamide (i-Eulexin) ngokushesha okukhulu. Ngokomqondo, ukuthatha i-guarana kanye ne-flutamide (i-Eulexin) kungadala i-flutamide (i-Eulexin) eningi kakhulu emzimbeni futhi kwandise ubungozi bemiphumela emibi.
I-Fluvoxamine (Luvox)
Umzimba wephula i-caffeine ese-guarana ukuze uyiqede. I-Fluvoxamine (Luvox) inganciphisa ukuthi umzimba uyiphula masinyane kanjani i-caffeine. Ukuthatha i-guarana kanye ne-fluvoxamine (i-Luvox) kungadala i-caffeine eningi kakhulu emzimbeni, futhi kwandise imiphumela kanye nemiphumela emibi ye-caffeine.
ILithium
Umzimba wakho ngokwemvelo ususa i-lithium. I-caffeine ese-guarana ingakhuphula ukuthi umzimba wakho ususa i-lithium ngokushesha kangakanani. Uma uthatha imikhiqizo equkethe i-caffeine futhi uphuza i-lithium, yeka ukuthatha imikhiqizo ye-caffeine kancane. Ukuyeka i-caffeine ngokushesha kungakhuphula imiphumela emibi ye-lithium.
Imithi ye-asthma (i-Beta-adrenergic agonists)
IGuarana iqukethe i-caffeine. I-caffeine ingashukumisa inhliziyo. Eminye imishanguzo ye-asthma nayo ingashukumisa inhliziyo. Ukuthatha i-caffeine ngemithi ethile ye-asthma kungadala ukukhuthazeka kakhulu futhi kubangele izinkinga zenhliziyo.

Eminye imithi yesifo somoya ihlanganisa i-albuterol (i-Proventil, i-Ventolin, i-Volmax), i-metaproterenol (i-Alupent), i-terbutaline (i-Bricanyl, i-Brethine) ne-isoproterenol (i-Isuprel).
Imithi yokudangala (MAOIs)
IGuarana iqukethe i-caffeine. I-caffeine ingakhuthaza umzimba. Eminye imishanguzo esetshenziselwa ukucindezeleka nayo ingakhuthaza umzimba. Ukuthatha i-guarana ngale mithi esetshenziselwa ukudangala kungadala imiphumela emibi kakhulu kubandakanya ukushaya kwenhliziyo okusheshayo, umfutho wegazi ophakeme, uvalo nabanye.

Eminye yale mithi esetshenziselwa ukucindezeleka ifaka phakathi i-phenelzine (Nardil), i-tranylcypromine (i-Parnate), neminye.
Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)
IGuarana iqukethe i-caffeine. I-caffeine inganciphisa ukuvimba kwegazi. Ukuthatha i-guarana kanye nemithi epholisa nokujiya komzimba kungakhuphula amathuba okulimala nokopha.

Eminye imishanguzo eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-clopidogrel (i-Plavix), i-diclofenac (i-Voltaren, i-Cataflam, abanye), i-ibuprofen (i-Advil, i-Motrin, abanye), i-naproxen (i-Anaprox, i-Naprosyn, abanye), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox) , heparin, warfarin (Coumadin), nabanye.
I-Nicotine
Izidakamizwa ezikhuthazayo ezifana ne-nicotine zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi ikhuphule izinga lokushaya kwenhliziyo yakho. I-caffeine ese-guarana nayo ingasheshisa isimiso sezinzwa. Ukuthatha i-guarana kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kubandakanya ukukhuphuka kwenhliziyo nomfutho wegazi ophezulu. Gwema ukuthatha izidakamizwa ezivuselelayo kanye ne-caffeine.
I-Pentobarbital (Nembutal)
Imiphumela evuselelayo ye-caffeine e-guarana ingavimba imiphumela ekhiqiza ukulala ye-pentobarbital.
I-Phenobarbital
I-Phenobarbital isetshenziselwa ukulawula ezinye izinhlobo zokubanjwa. I-caffeine, equkethwe ku-guarana, ingehlisa imiphumela ye-phenobarbital noma inyuse ukuthi umuntu uthinteka kalula kanjani ekuqulekeni. Ngokwethiyori, ukuthatha i-guarana nge-phenobarbital kunganciphisa imiphumela yayo futhi kukhuphule ubungozi bokuquleka.
I-Phenylpropanolamine
I-caffeine ese-guarana ingawushukumisa umzimba. I-Phenylpropanolamine nayo ingashukumisa umzimba. Ukuthatha i-guarana kanye ne-phenylpropanolamine kungadala ukukhuthazeka okukhulu futhi kukhulise ukushaya kwenhliziyo, umfutho wegazi futhi kubangele ukwethuka.
Phenytoin
I-Phenytoin isetshenziselwa ukulawula ezinye izinhlobo zokubanjwa. I-caffeine e-guarana ingahle yehlise imiphumela ye-phenytoin noma inyuse ukuthi umuntu angangenwa kanjani ukuquleka. Ngokwethiyori, ukuthatha i-guarana nge-phenytoin kunganciphisa imiphumela yayo futhi kukhuphule ubungozi bokuquleka.
Isi-Riluzole (Rilutek)
Umzimba wephula i-riluzole (Rilutek) ukuze uyiqede. Ukuthatha i-guarana kunganciphisa ukuthi umzimba wephula kanjani i-riluzole (i-Rilutek) ngokushesha futhi kukhulise imiphumela kanye nemiphumela emibi ye-riluzole.
Izidakamizwa ezikhuthazayo
Izidakamizwa ezikhuthazayo zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi isheshise ukushaya kwenhliziyo yakho. IGuarana iqukethe i-caffeine, nayo engasheshisa isimiso sezinzwa. Ukuthatha i-guarana kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kubandakanya ukukhuphuka kwenhliziyo nomfutho wegazi ophezulu. Gwema ukuthatha izidakamizwa ezikhuthazayo kanye ne-guarana.

Eminye imishanguzo evuselelayo ifaka i-nicotine, i-cocaine, i-sympathomimetic amines, ne-amphetamines.
Theophylline
IGuarana iqukethe i-caffeine. I-caffeine isebenza ngokufanayo ne-theophylline. I-caffeine nayo inganciphisa ukuthi umzimba ususa kanjani i-theophylline ngokushesha okukhulu. Ukuthatha i-guarana kanye ne-theophylline kungakhuphula imiphumela kanye nemiphumela emibi ye-theophylline.
I-Valproate
IValproate isetshenziselwa ukulawula ezinye izinhlobo zokubanjwa. I-caffeine e-guarana ingahle yehlise imiphumela ye-valproate noma inyuse ukuthi umuntu angangenwa kanjani ukuquleka. Ngokwethiyori, ukuthatha i-guarana nge-valproate kunganciphisa imiphumela yayo futhi kukhuphule ubungozi bokuquleka.
I-Verapamil (Calan, Covera, Isoptin, Verelan)
Umzimba wephula i-caffeine ese-guarana ukuze uyiqede. IVerapamil (Calan, Covera, Isoptin, Verelan) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha. Ukuthatha i-guarana kanye ne-verapamil (Calan, Covera, Isoptin, Verelan) kungakhuphula ubungozi bemiphumela emibi ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu, nokushaya kwenhliziyo okwandayo.
Amaphilisi wamanzi (Imithi yokwelapha)
IGuarana iqukethe i-caffeine. I-caffeine inganciphisa amazinga e-potassium. "Amaphilisi amanzi" nawo anganciphisa amazinga e-potassium emzimbeni. Ngokwethiyori, ukuphuza i-guarana ngamaphilisi amanzi kungadala ukuthi amazinga e-potassium ehle kakhulu.
Amanye "amaphilisi amanzi" angaqeda i-potassium afaka i-chlorothiazide (Diuril), chlorthalidone (Thalitone), furosemide (Lasix), hydrochlorothiazide (HCTZ, HydroDiuril, Microzide), namanye.
Okuncane
Qaphela ngale nhlanganisela.
Utshwala
Umzimba wephula i-caffeine ese-guarana ukuze uyiqede. Utshwala bunganciphisa ukuthi umzimba wephula ngokushesha kangakanani i-caffeine. Ukuthatha i-guarana kanye notshwala kungahle kudale i-caffeine eningi egazini nasemiphumeleni emibi ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu, nokushaya kwenhliziyo okusheshayo.
Ama-antibiotic (ama-antibiotic e-Quinolone)
Umzimba wephula i-caffeine kusuka e-guarana ukuze uyiqede. Eminye imishanguzo inganciphisa ukuthi umzimba uphula ngokushesha kanjani i-caffeine. Ukuthatha le mithi kanye ne-guarana kungakhuphula ubungozi bemiphumela emibi kubandakanya i-jitteriness, ikhanda elibuhlungu, ukukhuphuka kwenhliziyo, nokunye.

Amanye ama-antibiotic anciphisa ukuthi umzimba uphula kanjani ngokushesha i-caffeine afaka i-ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), namanye
Amaphilisi okulawula inzalo (Izidakamizwa zokuvimbela inzalo)
Umzimba wephula i-caffeine ese-guarana ukuze uyiqede. Amaphilisi okulawula ukubeletha anganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukuthatha i-guarana kanye namaphilisi okulawula ukubeletha kungadala ukuqina, ikhanda, ukushaya kwenhliziyo okusheshayo, neminye imiphumela emibi.

Amanye amaphilisi okulawula ukubeletha afaka i-ethinyl estradiol ne-levonorgestrel (Triphasil), i-ethinyl estradiol ne-norethindrone (i-Ortho-Novum 1/35, i-Ortho-Novum 7/7/7), namanye.
I-Fluconazole (Diflucan)
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Fluconazole (i-Diflucan) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha Ukuthatha i-guarana kanye ne-fluconazole (i-Diflucan) kungakhuphula ubungozi bemiphumela emibi ye-caffeine njengokwethuka, ukukhathazeka nokuqwasha.
Imithi yesifo sikashukela (Imithi elwa nesifo sikashukela)
IGuarana ingakhuphula ushukela wegazi. Imithi yesifo sikashukela isetshenziselwa ukwehlisa ushukela wegazi. Ngokwandisa ushukela wegazi, i-guarana inganciphisa ukusebenza kwemithi yesifo sikashukela. Bheka ushukela wegazi lakho eduze. Umthamo wemithi yakho yesifo sikashukela ungadinga ukuguqulwa.

Eminye imithi esetshenziselwa isifo sikashukela ifaka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .
Imithi eyehlisa ukuwohloka kweminye imithi ngesibindi (I-Cytochrome P450 1A2 (CYP1A2) inhibitors)
IGuarana iqukethe i-caffeine. I-caffeine iyashintshwa futhi yephuke isibindi. Eminye imishanguzo iyancipha ukuthi isibindi sishintsha ngokushesha kangakanani futhi siphula imishanguzo kanye nezithasiselo ezithile. Ukuthatha i-guarana kanye nale mithi kunganciphisa ukonakala kwe-caffeine futhi kwandise amazinga e-caffeine.
Eminye yale mithi ethinta isibindi ihlanganisa i-fluvoxamine, i-mexiletine, i-clozapine, i-psoralens, i-furafylline, i-theophylline, i-idrocilamide, neminye.
I-Metformin
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. IMetformin inganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukuthatha i-metformin kanye ne-guarana kungakhuphula imiphumela kanye nemiphumela emibi ye-caffeine.
Methoxsalen
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Methoxsalen inganciphisa ukuthi umzimba uphuka ngokushesha kanjani i-caffeine. Ukuthatha i-methoxsalen kanye ne-guarana kungakhuphula imiphumela kanye nemiphumela emibi ye-caffeine.
I-Mexiletine (Mexitil)
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Mexiletine (Mexitil) inganciphisa ukuthi umzimba wephula ngokushesha kanjani i-caffeine. Ukuthatha i-mexiletine (Mexitil) kanye ne-guarana kungakhuphula imiphumela ye-caffeine nemiphumela emibi ye-guarana.
Ama-phenothiazines
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. Ama-phenothiazines anganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukuthatha ama-phenothiazines kanye ne-guarana kungakhuphula imiphumela kanye nemiphumela emibi ye-caffeine.
I-Terbinafine (Lamisil)
Umzimba wephula i-caffeine (equkethwe ku-guarana) ukuze uyiqede. I-Terbinafine (i-Lamisil) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha futhi inyuse ubungozi bemiphumela emibi kubandakanya i-jitteriness, ikhanda elibuhlungu, ukushaya kwenhliziyo okwengeziwe, neminye imiphumela.
I-Tiagbine
I-Tiagabine isetshenziselwa ukulawula ezinye izinhlobo zokuquleka. I-caffeine e-guarana kubonakala ngathi ayinayo imiphumela ye-tiagabine. Kodwa-ke, ukusetshenziswa kwesikhathi eside kwe-caffeine kungakhuphula amazinga wegazi we-tiagabine. Ngokombono, ukusetshenziswa kwesikhathi eside kwe-guarana kungaba nomphumela ofanayo.
I-Ticlopidine (Ticlid)
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Ticlopidine (Ticlid) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha okukhulu. Ngokwethiyori, ukuthatha i-guarana kanye ne-ticlopidine (Ticlid) kungakhuphula ubungozi bemiphumela emibi ye-caffeine.
Okumunyu okusawolintshi
IGuarana iqukethe i-caffeine. Ukuthatha iwolintshi elibabayo kanye namakhambi ane-caffeine, i-guarana, kungakhuphula umfutho wegazi nokushaya kwenhliziyo kubantu abane-blood pressure evamile. Lokhu kungakhuphula amathuba okuba nezinkinga ngenhliziyo nangemithambo yegazi.
Amakhambi aqukethe i-caffeine nezithako
IGuarana iqukethe i-caffeine. Ukuyithatha ngamanye amakhambi nezithako eziqukethe i-caffeine kungakhuphula kokubili imiphumela eyingozi newusizo ye-caffeine. Eminye imikhiqizo yemvelo equkethe i-caffeine ifaka phakathi ikhofi, itiye elimnyama, itiye eliluhlaza, itiye le-oolong, itiye le-pu-erh, umlingani ne-cola.
I-calcium
Ukudla okuphezulu kwe-caffeine ekudleni, iziphuzo, namakhambi kufaka phakathi i-guarana kwandisa ukukhishwa kwe-calcium yomchamo.
I-Creatine
Kukhona ukukhathazeka okuthile ukuthi ukuhlanganisa i-caffeine, i-ephedra, ne-creatine kungakhuphula ubungozi bemiphumela emibi kakhulu. Kunombiko wokushaywa unhlangothi kumsubathi othathe i-6 gram ye-creatine monohydrate, i-400-600 mg ye-caffeine, i-40-60 mg ye-ephedra, nezinye izithasiselo ezahlukahlukene nsuku zonke amasonto ayisithupha. I-caffeine ingahle yehlise nemiphumela emihle yokudala ekusebenzeni kwezemidlalo.
I-Danshen
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Danshen ingahle yehle ukuthi umzimba wephula ngokushesha kangakanani i-caffeine. Sebenzisa i-danshen nge-guarana kungakhuphula amazinga e-caffeine.
I-Echinachea
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Echinacea ingahle yehlise ukuthi umzimba wephula ngokushesha kangakanani i-caffeine. Sebenzisa i-echinacea ne-guarana kungakhuphula amazinga e-caffeine.
I-Ephedra (Ma huang)
I-Ephedra iyashukumisa. IGuarana iyashukumisa, ngenxa yokuqukethwe yi-caffeine. Ukusebenzisa i-ephedra kanye ne-guarana kungadala ukukhuthazeka okuningi emzimbeni. Umbiko owodwa ongashicilelwe uxhuma ukuba muncu, umfutho wegazi ophakeme, ukuquleka, ukulahlekelwa ukwazi okwesikhashana, nokulaliswa esibhedlela okudinga ukwesekwa ngempilo kusetshenziswa inhlanganisela ye-ephedra ne-guarana (caffeine). Ungathathi i-guarana nge-ephedra noma ezinye izikhuthazi.
Amakhambi nezithako ezihamba kancane ekunqandeni kwegazi (Anticoagulant / Antiplatelet herbs and supplements
IGuarana ibonakala ikwazi ukwehlisa ukunqamuka kwegazi. Ukuyisebenzisa kanye namanye amakhambi nezithasiselo futhi ezihamba kancane ekunqandeni kwegazi kungakhuphula ingozi yokopha kwabanye abantu. Amanye ala makhambi afaka i-angelica, i-clove, i-danshen, i-garlic, i-ginger, i-ginkgo, ne-Panax ginseng.
UKudzu
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. UKudzu angahle anciphise ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukusebenzisa i-kudzu ne-guarana kungakhuphula amazinga e-caffeine.
Magnesium
Ukudla okuphezulu kwe-caffeine ekudleni, iziphuzo, namakhambi kufaka phakathi i-guarana kwandisa ukuphuma kwe-magnesium.
I-Melatonin
IGuarana iqukethe i-caffeine. Ukuthatha i-caffeine kanye ne-melatonin kungakhuphula amazinga e-melatonin. Ngokwethiyori, ukuthatha i-guarana nge-melatonin nakho kungakhuphula amazinga e-melatonin.
I-clover ebomvu
IGuarana iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. Ukuthatha i-red clover kunganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ngokwethiyori, ukuthatha i-clover ebomvu nge-guarana kungakhuphula amazinga e-caffeine.
Akukho ukuxhumana okwaziwayo nokudla.
Umthamo ofanele we-guarana uncike ezicini eziningana ezifana nobudala bomsebenzisi, impilo, nezinye izimo eziningana. Ngalesi sikhathi alukho ulwazi olwanele lwesayensi ukunquma uhla olufanele lwamanani we-guarana. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa.

I-cocoa yaseBrazil, i-Cacao Brésilien, i-Guarana Seed Extract, i-Guaranine, i-Paullinia cupana, i-Paullinia sorbilis, i-Zoom.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. Nguyen S, Rajfer J, Shaheen M. Ukuphepha nokusebenza kwe-Revactin yansuku zonke emadodeni anokungasebenzi kahle kwe-erectile: isifundo sezindiza sezinyanga ezi-3. Humusha u-Androl Urol. 2018; 7: 266-73. Buka okungaqondakali.
  2. ISilva CP, iSampaio GR, iFreitas RAMS, iTorres EAFS. Ama-polyphenols avela ku-guaraná ngemuva kokugaywa kwe-in vitro: ukuhlolwa kokutholakala kwe-bioacessization kanye nokuvimbela ukusebenza kwama-enzyme e-carbohydrate-hydrolyzing. Ukudla Chem 2018; 267: 405-9. i-doi: 10.1016 / j.foodchem.2017.08.078. Buka okungaqondakali.
  3. ISette CVM, iRibas de Alcântara BB, iSchoueri JHM, et al. Kukhishwe i-Paullinia cupana (PC-18) ehlanziwe ehlanzelwe ukukhathala okubangelwa ngamakhemikhali: imiphumela yezilingo ezimbili zomtholampilo ezingaboni kahle. J Ukudla Suppl 2018; 15: 673-83. i-doi: 10.1080 / 19390211.2017.1384781. Buka okungaqondakali.
  4. U-Wikoff D, i-Welsh BT, uHenderson R, et al. Ukubuyekezwa okuhlelekile kwemiphumela emibi engaba khona yokusetshenziswa kwe-caffeine kubantu abadala abanempilo, abesifazane abakhulelwe, intsha kanye nezingane. Ukudla Chem Toxicol 2017; 109: 585-648. Buka okungaqondakali.
  5. I-Ciszowski K, i-Biedron W, i-Gomólka E. Ubuthi obunamandla be-caffeine obuholela ekufakweni kwe-atrial ngemuva kokukhishwa kwe-guarana ngokweqile. Przegl Lek. 2014; 71: 495-8. Buka okungaqondakali.
  6. UVeasey RC, uHaskell-Ramsay CF, uKennedy DO, uWishart K, uMaggini S, uFuchs CJ, uStevenson EJ. Imiphumela Yokwengezelelwa nge-Vitamin neMamineral Complex eneGuaraná Ngaphambi Kokuzivocavoca Okusheshayo Kokuthinta, Ukuzikhandla, Ukusebenza Kokuqonda, kanye ne-Substrate Metabolism: Isivivinyo Esilawulwa Ngokungahleliwe. Izakhamzimba. 2015 Julayi 27; 7: 6109-27. Buka okungaqondakali.
  7. I-Silvestrini GI, i-Marino F, i-Cosentino M. Imiphumela yomkhiqizo wezohwebo oqukethe i-guaraná enhlalakahleni yezengqondo, ukukhathazeka nemizwelo: isifundo esilawulwa yimpumputhe esisodwa, esilawulwa yi-placebo ezifundweni ezinempilo. Imiphumela ye-J Negat Biomed. 2013 Meyi 25; 12: 9. Buka okungaqondakali.
  8. Scholey A, Bauer I, Neale C, Savage K, Camfield D, White D, Maggini S, Pipingas A, Stough C, Hughes M. Imiphumela emibi yamalungiselelo amaminerali e-multivitamin ahlukahlukene nangaphandle kweGuaraná kwemizwa, ukusebenza kwengqondo kanye nokusebenza kobuchopho obusebenzayo . Izakhamzimba. 2013 Sep 13; 5: 3589-604. Buka okungaqondakali.
  9. I-Pomportes L, i-Davranche K, i-Brisswalter I, i-Hays A, i-Brisswalter J. Ukuhluka kwesilinganiso senhliziyo nokusebenza kwengqondo kulandela ukwengezelwa kwamavithamini amaningi namaminerali nge-guarana eyengeziwe (Paullinia cupana). Izakhamzimba. 2014 Disemba 31; 7: 196-208. Buka okungaqondakali.
  10. Palma CG, Lera AT, Lerner T, de Oliveira MM, de Borta TM, Barbosa RP, Brito GM, Guazzelli CA, Cruz FJ, del Giglio A. Guarana (Paullinia cupana) Kuthuthukisa i-Anorexia ezigulini ezinomdlavuza othuthukile. J Ukudla Suppl. 2016; 13: 221-31. Buka okungaqondakali.
  11. UMoustakas D, uMezzio M, uRodriguez BR, uConstable MA, uMulligan ME, uVoura EB. IGuarana inikeza ukukhuthazwa okwengeziwe nge-caffeine yodwa kwimodeli yeplanethi. Ama-PLoS One. 2015 Ephreli 16; 10: e0123310. Buka okungaqondakali.
  12. UKennedy DO, uHaskell CF, uRobertson B, uRay J, uBrewster-Maund C, uLuedemann J, uMaggini S, uRuf M, uZangara A, uScholey AB. Ukusebenza okuthuthukile kokuqonda nokukhathala kwengqondo kulandela ukwengezelwa kwamavithamini namaminerali amaningi nge-guaraná eyengeziwe (Paullinia cupana). Ukulangazelela ukudla. 2008 uMar-Meyi; 50 (2-3): 506-13. Buka okungaqondakali.
  13. UHaskell CF, Kennedy DO, Wesnes KA, Milne AL, Scholey AB. Ukuhlolwa okuyimpumputhe kabili, okulawulwa yi-placebo, kwemithamo eminingi yemiphumela emibi yokuziphatha kwe-guaraná ebantwini. J I-Psychopharmacol. 2007 uJan; 21: 65-70. Buka okungaqondakali.
  14. del Giglio AB, Cubero Dde I, Lerner TG, Guariento RT, de Azevedo RG, Paiva H, Goldman C, Carelli B, Cruz FM, Schindler F, Pianowski L, de Matos LL, del Giglio A. Ukuhlanzwa okwomile kwe-Paullinia cupana (guaraná) (PC-18) yokukhathala okuhlobene nokwelashwa ngamakhemikhali ezigulini ezinamathumba aqinile: isifundo sokuqala sokuyeka. J Ukudla Suppl. 2013 Dis; 10: 325-34. Buka okungaqondakali.
  15. de Oliveira Campos MP, Riechelmann R, Martins LC, Hassan BJ, Casa FB, Del Giglio A. Guarana (Paullinia cupana) kuthuthukisa ukukhathala ezigulini zomdlavuza webele ezelashwa ngamakhemikhali e-systemic. UJ Altern Complement Med. 2011 uJuni; 17: 505-12. Buka okungaqondakali.
  16. da Costa Miranda V, Trufelli DC, Santos J, MP Campos, Nobuo M, da Costa Miranda M, Schlinder F, Riechelmann R, del Giglio A.Ukusebenza kwe-guarana (Paullinia cupana) yokukhathala kwangemva kokushisa nokudangala: imiphumela yomshayeli ophindwe kabili -blind isifundo esingahleliwe. UJ Altern Complement Med. 2009 Ephreli; 15: 431-3. Buka okungaqondakali.
  17. van der Hoeven N, Visser I, Schene A, van den Born BJ. Umfutho wegazi ophakeme ohlobene nekhofi ene-caffeine ne-tranylcypromine: umbiko wecala. U-Ann Intern Med. 2014 Meyi 6; 160: 657-8. i-doi: 10.7326 / L14-5009-8. Akukho okungajwayelekile okutholakalayo. Buka okungaqondakali.
  18. UPeng PJ, uChiang KT, uLiang CS. I-caffeine enomthamo ophansi ingakhuphula izimpawu zengqondo kubantu abane-schizophrenia. Umtholampilo waseJ Neuropsychiatry Neurosci. 2014 Ephreli 1; 26: E41. i-doi: 10.1176 / appi.neuropsych.13040098. Akukho okungajwayelekile okutholakalayo. Buka okungaqondakali.
  19. UBrice C noSmith A. Imiphumela ye-caffeine ekushayeleni okulingisiwe, ukuqapha okuzenzakalelayo nokunakwa okuqhubekayo. I-Hum Psychopharmacol Clin Exp I-2001; 16: 523-531.
  20. I-Bempong DK, i-Houghton PJ, ne-Steadman K. Okuqukethwe kwe-xanthine kwe-guarana namalungiselelo ayo. I-Int J Pharmacog 1993; 31: 175-181.
  21. UMarx, F. no-al. Ukuhlaziywa kwe-guaraná (
  22. UChamone, D. A., Silva, M. I., Cassaro, C., Bellotti, G., Massumoto, C.M, noFujimura, A. Y. Guaraná (Paullinia cupana) kuvimbela ukuhlangana egazini lonke. I-Thrombosis neHaemostasis 1987; 58: 474.
  23. Rejent T, Michalek R, and Krajewski M. Caffeine fatality with coincident ephedrine. IBull Int Assoc Forensic Toxicol 1981; 16: 18-19.
  24. Khodesevick AP. Ubuthi obubulala i-caffeine (icala elivela ekusebenzeni). IPulaziakol Toksikol 1956; 19 (suppl): 62.
  25. UDrew AK noDawson AH. I-Herbal xtreme: ubuthi obuyingozi obuhambisana ne-intravenous guarana [abstract]. Ijenali yeToxicology - Clinical Toxicology 2000; 38: 235-236.
  26. URyall JE. Ukufa kwe-caffeine ne-ephedrine. IBull Int Assoc Forensic Toxicol 1984; 17: 13.
  27. Mattei, R., Dias, R. F., Espinola, E. B., Carlini, E. A., noBarros, S. B. Guarana (Paullinia cupana): imiphumela enobuthi yokuziphatha ezilwaneni zaselabhorethri nasemisebenzini yama-antioxidants in vitro. J. Ethnopharmacol. 1998; 60: 111-116. Buka okungaqondakali.
  28. UGalduroz, J. C. noCarlini, E. A. Imiphumela yokuphathwa kwesikhathi eside kwe-guarana ekwazini amavolontiya ajwayelekile, asebekhulile. I-Sao Paulo Med. J. 1996; 114: 1073-1078. Buka okungaqondakali.
  29. UBenoni, H., Dallakian, P., noTaraz, K. Ucwaningo ngamafutha abalulekile avela e-guarana. Z. Lebensm.Unters.Forsch. 1996; 203: 95-98. Buka okungaqondakali.
  30. UDebrah, K., Haigh, R., Sherwin, R., Murphy, J., noKerr, D. Umphumela wokusetshenziswa kwe-caffeine ebukhali futhi engapheli ekusetshenzisweni kwe-cerebrovascular, cardiovascular and hormonal ku-orthostasis kumavolontiya anempilo. I-Clin Sci (Colch.) 1995; 89: 475-480. Buka okungaqondakali.
  31. USalvadori, M. C., Rieser, E. M., Ribeiro Neto, L. M., noNascimento, E. S. Ukunqunywa kwe-xanthines nge-chromatography esebenza kahle kakhulu kanye ne-chromatography emincane emgqeni wehhashi ngemuva kokumunca i-Guarana powder. Umhlaziyi 1994; 119: 2701-2703. Buka okungaqondakali.
  32. UGalduroz, J. C. noCarlini, Ede A. Imiphumela emibi yePaulinia cupana, "iGuarana" ekuqondeni amavolontiya ajwayelekile. I-Sao Paulo Med. J. 1994; 112: 607-611. Buka okungaqondakali.
  33. Belliardo, F., Martelli, A., noValle, M. G. HPLC ukuzimisela kwe-caffeine ne-theophylline ePaullinia cupana Kunth (guarana) naseCola spp. amasampula. Z. Lebensm.Unters.Forsch. 1985; 180: 398-401. Buka okungaqondakali.
  34. I-Bydlowski, S. P., Yunker, R. L., ne-Subbiah, M. T. Impahla yenoveli yokukhishwa kwe-guarana enamanzi (Paullinia cupana): ukuvimbela ukuhlanganiswa kweplatelet in vitro naku-vivo. I-Braz.J.Med.I-Biol.Izinkinga. 1988; 21: 535-538. Buka okungaqondakali.
  35. I-Bydlowski, S. P., D'Amico, E. A., ne-Chamone, D. A. Ukukhishwa okunamanzi kwe-guarana (Paullinia cupana) kunciphisa i-platelet thromboxane synthesis. I-Braz.J.Med.I-Biol.Izinkinga 1991; 24: 421-424. Buka okungaqondakali.
  36. Haller, C. A., Jacob, P., noBenowitz, N. L. Imiphumela yesikhashana yesikhashana ye-metabolic ne-hemodynamic yenhlanganisela ye-ephedra ne-guarana. Umtholampilo. Pharmacol. 2005; 77: 560-571. Buka okungaqondakali.
  37. UKennedy, D. O., Haskell, C. F., Wesnes, K. A., noScholey, A. B. Ukusebenza okuthuthukisiwe kokuqonda kumavolontiya abantu kulandela ukuphathwa kwe-guarana (Paullinia cupana) kukhishwa: ukuqhathanisa nokusebenzisana noPanax ginseng. I-Pharmacol Biochem Behav 2004; 79: 401-411. Buka okungaqondakali.
  38. UBaghkhani, L. noJafari, M. Ukusabela okweqile kwenhliziyo okuhambisana neGuarana: kukhona umphumela oyimbangela? J.Herb.Umakhemikhali. 2002; 2: 57-61. Buka okungaqondakali.
  39. U-Avato, P., Pesante, M. A., Fanizzi, F. P., noSantos, C. A. Ukwakheka kukawoyela wembewu kaPaullinia cupana var. i-sorbilis (Mart.) Ducke. I-Lipids 2003; 38: 773-780. Buka okungaqondakali.
  40. USmith, A. P., Kendrick, A. M., noMaben, A. L. Imiphumela yokudla kwasekuseni ne-caffeine ekusebenzeni nasesimweni sezulu ekuseni nangemva kwesidlo sasemini. I-Neuropsychobiology 1992; 26: 198-204. Buka okungaqondakali.
  41. de Oliveira, JF, Avila, AS, Braga, AC, de Oliveira, MB, Boasquevisque, EM, Jales, RL, Cardoso, VN, noBernardo-Filho, M. Umphumela wokukhishwa kwezitshalo zokwelapha ekubhaleni izinto zegazi nge I-Technetium-99m kanye ne-morphology yamaseli abomvu egazi: I - isifundo noPaullinia cupana. UFitoterapia 2002; 73: 305-312. Buka okungaqondakali.
  42. USmits, P., Corstens, F.H, Aengevaeren, W. R., Wackers, F. J., noTeen, T. Amanga-okungekho emthethweni nge-dipyridamole-thallium-201 imaging myocardial ngemuva kokufakwa kwe-caffeine. UJ Nucl.Uphakathi. 1991; 32: 1538-1541. Buka okungaqondakali.
  43. du, Boisgueheneuc F., Lannuzel, A., Caparros-Lefebvre, D., noDe Broucker, T. [I-Cerebral infarction esigulini esisebenzisa i-MaHuang extract ne-guarana]. Phakamisa iMed 2-3-2001; 30: 166-167. Buka okungaqondakali.
  44. Lloyd, T., Rollings, N., Eggli, D. F., Kieselhorst, K., noChinchilli, V. M. Ukudla kwe-caffeine kanye nesimo samathambo sabesifazane be-postmenopausal. NginguJ. J.Clin. Nutr. 1997; 65: 1826-1830. Buka okungaqondakali.
  45. USicard, B. A., Perault, M. C., Enslen, M., Chauffard, F., Vandel, B., noTachon, P. Imiphumela ye-600 mg ye-caffeine ekhishwa kancane kwimizwa nokuqapha. I-Aviat.Isikhala se-Environ.1996; 67: 859-862. Buka okungaqondakali.
  46. UMorano, A., Jimenez-Jimenez, F. J., Molina, J. A., no-Antolin, M. A. Izinto ezinobungozi zesifo sikaParkinson: isifundo sokulawulwa kwamacala esifundazweni saseCaceres, eSpain. I-Acta Neurol.Scand 1994; 89: 164-170. Buka okungaqondakali.
  47. UBlanchard, J. noSawers, S. J. Ukutholakala okuphelele kwe-caffeine kumuntu. Eur.J.Clin.Pharmacol. 1983; 24: 93-98. Buka okungaqondakali.
  48. UCuratolo, uP. W. noRobertson, D. Imiphumela yempilo ye-caffeine. U-Ann.Intern.Med. 1983; 98 (5 Pt 1): 641-653. Buka okungaqondakali.
  49. U-Astrup, A., Toubro, S., Cannon, S., Hein, P., Breum, L., noMadsen, J. Caffeine: isifundo esilawulwa kabili, esilawulwa yi-placebo semiphumela yaso ye-thermogenic, metabolic, kanye nenhliziyo. kumavolontiya anempilo. NginguJ. J.Clin. Nutr. 1990; 51: 759-767. Buka okungaqondakali.
  50. I-Pappa, HM, Saslowsky, TM, Filip-Dhima, R., DiFabio, D., Lahsinoui, HH, Akkad, A., Grand, RJ, noGordon, CM Ukusebenza kahle nokulimaza kwe-nasal calcitonin ekuthuthukiseni ukuminyana kwethambo ezigulini ezisencane ngesifo samathumbu esivuthayo: isilingo esingahleliwe, esilawulwa yi-placebo, esiyimpumputhe kabili. NginguJ Gastroenterol. 2011; 106: 1527-1543. Buka okungaqondakali.
  51. Orozco-Gregorio, H., Mota-Rojas, D., Bonilla-Jaime, H., Trujillo-Ortega, ME, Becerril-Herrera, M., Hernandez-Gonzalez, R., noVillanueva-Garcia, D. Imiphumela ye ukuphathwa kwe-caffeine kokuguquguqukayo kwemethodi ezingulubeni ezisanda kuzalwa ezine-peripartum asphyxia. NginguJ. J Vet. 2010; 71: 1214-1219. Buka okungaqondakali.
  52. UClausen, T. Ukuguqulwa kwamahomoni nokwenziwa kwemithi kwe-plasma potassium homeostasis. I-Fundam.Clin Pharmacol 2010; 24: 595-605. Buka okungaqondakali.
  53. U-Ernest, D., Chia, M., noCalloallo, C. E. I-hypokalaemia ejulile ngenxa yokusebenzisa kabi i-Nurofen Plus ne-Red Bull. Ukuvuselelwa Kwe-Crit Care. 2010; 12: 109-110. Buka okungaqondakali.
  54. UJha, R. M., Mithal, A., Malhotra, N., noBrown, u-E.M Pilot wecala lokulawula icala lezinto ezinobungozi zokuqhekeka kwe-hip kubantu base-Indian basemadolobheni. BMC.Musculoskelet.Ukuphazamiseka. 2010; 11: 49. Buka okungaqondakali.
  55. URigato, I., Blarasin, L., noKette, F. I-hypokalemia enzima kubagibeli abancane bebhayisikili abayi-2 ngenxa yokudla okukhulu kwe-caffeine. I-Clin J Sport Med. 2010; 20: 128-130. Buka okungaqondakali.
  56. IBarbour, KE, Zmuda, JM, Strotmeyer, ES, Horwitz, MJ, Boudreau, R., Evans, RW, Ensrud, KE, Petit, MA, Gordon, CL, noCauley, JA Correlates of trabecular and cortical volumetric bone mineral density we-radius ne-tibia emadodeni amadala: ama-Osteoporotic Fractures in Men Study. J Bone Umvukuzi. 2010; 25: 1017-1028. Buka okungaqondakali.
  57. UBuscemi, S., Verga, S., Batsis, JA, Donatelli, M., Tranchina, MR, Belmonte, S., Mattina, A., Re, A., noCerasola, G. Imiphumela emibi yekhofi ekusebenzeni kwe-endothelial ezifundweni ezinempilo. Eur.J Umsoco Wasemtholampilo. 2010; 64: 483-489. Buka okungaqondakali.
  58. USimmonds, M. J., Minahan, C. L., noSabapathy, S. Caffeine ithuthukisa ukuhamba ngebhayisikili okuphezulu kepha hhayi isilinganiso sokukhishwa kwamandla kwe-anaerobic. I-Eur. J Appl Physiol 2010; I-109: 287-295. Buka okungaqondakali.
  59. UJamal, SA, Swan, VJ, Brown, JP, Hanley, DA, Prior, JC, Papaioannou, A., Langsetmo, L., noJosse, RG ukusebenza kwezinso nezinga lokulahleka kwamathambo enqeni nasemgogodleni: iCanada Multicentre Isifundo Samathambo. Am J Izinso Dis. 2010; 55: 291-299. Buka okungaqondakali.
  60. UChroscinska-Krawczyk, M., Ratnaraj, N., Patsalos, P. N., noCzuczwar, S. J. Umphumela we-caffeine emiphumeleni ye-anticonvulsant ye-oxcarbazepine, lamotrigine kanye ne-tiagabine kwimodeli yegundane yokuhlaselwa okujwayelekile kwe-tonic-clonic. I-Pharmacol Rep. 2009; 61: 819-826. Buka okungaqondakali.
  61. UMoisey, uL. L., uRobinson, uL., NoGraham, u-T. Ukusetshenziswa kwekhofi ene-caffeine kanye nesidlo se-carbohydrate ephezulu kuthinta umzimba we-postprandial wokuhlolwa kokubekezelelana kwe-glucose ngomlomo kwabesilisa abancane, abanempilo. Br. J Umsoco. 2010; 103: 833-841. Buka okungaqondakali.
  62. U-Waugh, EJ, Lam, MA, Hawker, GA, McGowan, J., Papaioannou, A., Cheung, AM, Hodsman, AB, Leslie, WD, Siminoski, K., noJamal, SA Izici zobungozi zamathambo aphansi ku abesifazane abaneminyaka engama-40-60 abanempilo: ukubuyekezwa okuhlelekile kwezincwadi. I-Osteoporos.Int. 2009; 20: 1-21. Buka okungaqondakali.
  63. IMacKenzie, T., Comi, R., Sluss, P., Keisari, R., Manwar, S., Kim, J., Larson, R., noBaron, JA Imiphumela ye-Metabolic ne-hormonal ye-caffeine: okungahleliwe, okuphindwe kabili- isilingo se-crossover esilawulwa nge-placebo. I-Metabolism 2007; 56: 1694-1698. Buka okungaqondakali.
  64. UHansen, S. A., Folsom, A. R., Kushi, L.H, kanye nabathengisi, T. A. Inhlangano yokuqhekeka ne-caffeine notshwala kwabesifazane abangemva kokuya esikhathini: i-Iowa Women's Health Study. Umsoco Wezempilo Yomphakathi. 2000; 3: 253-261. Buka okungaqondakali.
  65. URobelin, M. noRogers, P. J. Mood kanye nemiphumela yokusebenza kwengqondo yokuqala, kodwa hhayi kokulandelayo, indebe yekhofi yokulinganisa okulinganayo kwe-caffeine okudliwe ngemuva kokuyeka i-caffeine ubusuku bonke. I-Pharm. I-Pharmacol 1998; 9: 611-618. Buka okungaqondakali.
  66. URogers, P.J noDernoncourt, C. Ukusetshenziswa njalo kwe-caffeine: ibhalansi yemiphumela emibi nezuzisayo yokusebenza kwemizwelo nokusebenza kwengqondo. I-Pharmacol Biochem.I-Behav. 1998; 59: 1039-1045. Buka okungaqondakali.
  67. UStein, M.A., Krasowski, M., Leventhal, B. L., Phillips, W., noBender, B. G. Imiphumela yokuziphatha nokuzicabangela kwemethylxanthines. Ukuhlaziywa kwe-meta kwe-theophylline ne-caffeine. Arch.Pediatr.Adolesc.Med. 1996; 150: 284-288. Buka okungaqondakali.
  68. ICaballero, T., Garcia-Ara, C., Pascual, C., Diaz-Pena, J. M., no-Ojeda, A. Urticaria eyenziwe yi-caffeine. J. Investig.I-Allergol.Clin Immunol. 1993; 3: 160-162. Buka okungaqondakali.
  69. Tassaneeyakul, W., Birkett, DJ, McManus, ME, Tassaneeyakul, W., Veronese, ME, Andersson, T., Tukey, RH, and Miners, JO Caffeine metabolism by cytochromes hepatic human P450: iminikelo ka 1A2, 2E1 no 3A isoforms. I-Biochem. I-Pharmacol 5-18-1994; 47: 1767-1776. Buka okungaqondakali.
  70. AmaParsons, uW. D. noPelletier, uJ. G. G. Kubambezelekile ukuqedwa kwe-caffeine ngabesifazane emasontweni amabili edlule wokukhulelwa. Can. Kucatshangwa. Assoc. J 9-1-1982; 127: 377-380. Buka okungaqondakali.
  71. UBlanchard, J. noSawers, S. J. Ukuqhathanisa ama-pharmacokinetics we-caffeine emadodeni amancane nasebekhulile. J Pharmacokinet.I-Biopharm. 1983; 11: 109-126. Buka okungaqondakali.
  72. UGrant, D. M., Tang, B. K., noKalow, W. Ukuguquguquka kwe-caffeine metabolism. I-Clin Pharmacol Ther 1983; 33: 591-602. Buka okungaqondakali.
  73. AmaParsons, uW. D. neNeims, A. H. Umphumela wokubhema ekusetshenzisweni kwe-caffeine. I-Clin Pharmacol Ther 1978; 24: 40-45. Buka okungaqondakali.
  74. Keuchel, I., Kohnen, R., noLienert, G. A. Imiphumela yotshwala ne-caffeine ekusebenzeni kokuhlolwa kokuhlushwa. Arzneimittelforschung. 1979; 29: 973-975. Buka okungaqondakali.
  75. U-Arnold, M. E., Petros, T. V., Beckwith, B. E., Coons, G., noGorman, N. Imiphumela ye-caffeine, impulsivity, kanye nezocansi kwimemori yohlu lwamagama. UPhysiol Behav. 1987; 41: 25-30. Buka okungaqondakali.
  76. URobertson, D., Frolich, J. C., Carr, R. K., Watson, J. T., Hollifield, J. W., Shand, D. G., no-Oates, J. A. Imiphumela ye-caffeine ekusebenzeni kwe-plasma renin, ama-catecholamines nomfutho wegazi. N.Engl.J Med. 1-26-1978; 298: 181-186. Buka okungaqondakali.
  77. UPola, J., Subiza, J., Armentia, A., Zapata, C., Hinojosa, M., Losada, E., noValdivieso, R. Urticaria obangelwa yi-caffeine. Ukungezwani komzimba no-Ann ngo-1988; 60: 207-208. Buka okungaqondakali.
  78. UWrenn, K. D. no-Oschner, I. I-Rhabdomyolysis ebangelwe ukudlula ngokweqile kwe-caffeine. U-Ann.Emerg.Uphakathi. 1989; 18: 94-97. Buka okungaqondakali.
  79. UQuirce, G. S., Freire, P., Fernandez, R. M., Davila, I., noLosada, E. Urticaria ovela kwi-caffeine. J. Ukungezwani komzimba ne-Immunol. 1991; 88: 680-681. Buka okungaqondakali.
  80. Yu, G., Maskray, V., Jackson, S. H., Swift, C. G., noTiplady, B. Ukuqhathaniswa kwemiphumela yesistimu yezinzwa ephakathi kwe-caffeine ne-theophylline ezifundweni ezindala. UBr. J Clin Pharmacol 1991; 32: 341-345. Buka okungaqondakali.
  81. URoberts, A.T, Jonge-Levitan, L., Parker, C. C., noGreenway, F. Umphumela wesengezo semithi equkethe itiye elimnyama ne-caffeine kumapharamitha we-metabolic kubantu. I-Altern Med Rev 2005; 10: 321-325. Buka okungaqondakali.
  82. UBryant, C. M., Dowell, C. J., noFairbrother, G. Caffeine ukunciphisa imfundo ukuthuthukisa izimpawu zomchamo. UBr. J. Nurs. 4-25-2002; 11: 560-565. Buka okungaqondakali.
  83. UConlisk, A. J. noGaruska, D. A. Ingabe i-caffeine ihlotshaniswa nobuningi bamathambo kwabesifazane asebekhulile abasebasha?. Okwangaphambilini. 2000; 31: 562-568. Buka okungaqondakali.
  84. U-Arya, L. A., Myers, D. L., noJackson, N. D. Ukudla kwe-caffeine kanye nengozi yokungazinzi kwe-detrusor: isifundo sokulawulwa kwamacala. Isikhubekiso. 2000; 96: 85-89. Buka okungaqondakali.
  85. U-Liu, T. T. no-Liau, J. Caffeine kwandisa ukulingana kwempendulo ebonakalayo ye-BOLD. I-Neuroimage. 2-1-2010; 49: 2311-2317. Buka okungaqondakali.
  86. Ursing, C., Wikner, J., Brismar, K., noRojdmark, S. Caffeine iphakamisa izinga le-serum melatonin ezifundweni ezinempilo: inkomba ye-melatonin metabolism yi-cytochrome P450 (CYP) 1A2. UJ. Endocrinol. Ukutshalwa kwezimali ngo-2003; 26: 403-406. Buka okungaqondakali.
  87. UHartter, S., Nordmark, A., Rose, D. M., Bertilsson, L., Tybring, G., noLaine, K. Imiphumela yokudla kwe-caffeine ku-pharmacokinetics ye-melatonin, umuthi wokuhlola umsebenzi we-CYP1A2. Br.J.Clin.Pharmacol. 2003; 56: 679-682. Buka okungaqondakali.
  88. UZheng, J., Chen, B., Jiang, B., Zeng, L., Tang, Z. R., Fan, L., noZhou, H. H. Imiphumela ye-puerarin ku-CYP2D6 nemisebenzi ye-CYP1A2 ku-vivo. I-Arch Pharm Res 2010; 33: 243-246. Buka okungaqondakali.
  89. Chen, Y., Xiao, CQ, He, YJ, Chen, BL, Wang, G., Zhou, G., Zhang, W., Tan, ZR, Cao, S., Wang, LP, noZhou, HH Genistein. kushintsha ukuvezwa kwe-caffeine kumavolontiya abesifazane aphilile. Umtholampilo wase-Eur. J. Pharmacol. 2011; 67: 347-353. Buka okungaqondakali.
  90. Gorski, JC, Huang, SM, Pinto, A., Hamman, MA, Hilligoss, JK, Zaheer, NA, Desai, M., Miller, M., kanye neHolo, SD Umphumela we-echinacea (Echinacea purpurea root) ku-cytochrome Umsebenzi we-P450 ku-vivo. Umtholampilo Pharmacol Ther. 2004; 75: 89-100. Buka okungaqondakali.
  91. U-Wang, X. no-Yeung, J. H. Imiphumela yokukhishwa okunamanzi okuvela eSalvia miltiorrhiza Bunge ku-caffeine pharmacokinetics kanye nomsebenzi wesibindi we-CYP1A2 kubantu nakamagundane. UJ Pharm Pharmacol 2010; 62: 1077-1083. Buka okungaqondakali.
  92. UNorager, C. B., Jensen, M. B., Weimann, A., noMadsen, M. R. Imiphumela ye-Metabolic yokungenisa i-caffeine nomsebenzi womzimba kwizakhamizi ezineminyaka engama-75 ubudala. Isifundo esilawulwa ngokungahleliwe, esingaboni kabili, esilawulwa yi-placebo. I-Clin Endocrinol (Oxf) 2006; 65: 223-228. Buka okungaqondakali.
  93. UDaniel, W. A., Syrek, M., Rylko, Z., noKot, M. Imiphumela ye-phenothiazine neuroleptics esilinganisweni se-caffeine demethylation ne-hydroxylation esibindini segundane. IPol. J Pharmacol 2001; 53: 615-621. Buka okungaqondakali.
  94. UWojcikowski, J. noDaniel, W. A. ​​Perazine ekugxileni kwezidakamizwa zokwelapha kuvimbela i-cytochrome yomuntu i-P450 isoenzyme 1A2 (CYP1A2) ne-caffeine metabolism - isifundo se-in vitro. I-Pharmacol Rep. 2009; 61: 851-858. Buka okungaqondakali.
  95. IMay, D. C., Camisa, C., Cheney, P., Pacula, C. M., Nawoot, S., noGerber, N. Methoxsalen yisithiyo esinamandla semetabolism ye-caffeine ebantwini. Umtholampilo. Pharmacol. 1987; 42: 621-626. Buka okungaqondakali.
  96. UMohiuddin, M., Azam, A. T., Amran, M. S., noHossain, M. A. Ngemiphumela emihle ye-gliclazide ne-metformin ekugxileni kwe-plasma ye-caffeine kumagundane anempilo. UPak. J Biol Sci 5-1-2009; 12: 734-737. Buka okungaqondakali.
  97. UGasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, WA, Kleinrok, Z., noCzuczwar, uSJ Felbamate ukhombisa ukuthambekela okuphansi kokusebenzisana ne-methylxanthines kanye ne-Ca2 + modulators yesiteshi ekulweni nokuquleka kokuhlola kumagundane. . I-Eur. J Pharmacol 7-10-1998; 352 (2-3): 207-214. Buka okungaqondakali.
  98. UVaz, J., Kulkarni, C., David, J., noJoseph, T. Umthelela we-caffeine kuphrofayli ye-pharmacokinetic ye-sodium valproate ne-carbamazepine kumavolontiya avamile abantu. Indian J.Exp.Ibhayisikili. 1998; 36: 112-114. Buka okungaqondakali.
  99. UChroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., noCzuczwar, S. J. Caffeine kanye ne-anticonvulsant potency yezidakamizwa ze-antiepileptic: idatha yokuhlola neyomtholampilo. IPharmacol. 2011; 63: 12-18. Buka okungaqondakali.
  100. ILuszczki, J. J., Zuchora, M., Sawicka, K. M., Kozinska, J., noCzuczwar, S. J. Ukuvezwa kahle kwe-caffeine kunciphisa isenzo se-anticonvulsant se-ethosuximide, kepha hhayi i-clonazepam, i-phenobarbital ne-valproate ekulweni nokuhlaselwa okubangelwa yi-pentetrazole kumagundane. I-Pharmacol Rep. 2006; 58: 652-659. Buka okungaqondakali.
  101. UJankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., noCzuczwar, S. J. [I-caffeine nemithi yokulwa nesifo sokuwa: idatha yokuhlola neyomtholampilo]. I-Przegl.Lek. 2007; 64: 965-967. Buka okungaqondakali.
  102. UGasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., noCzuczwar, S. J. Umsebenzi we-Anticonvulsant we-phenobarbital ne-valproate yokulwa ne-electroshock enkulu kumagundane ngesikhathi sokwelapha okungapheli nge-caffeine ne-caffeine yokuyeka. Isifo sokuwa 1996; 37: 262-268. Buka okungaqondakali.
  103. UKot, M. noDaniel, W. A. ​​Umphumela we-diethyldithiocarbamate (DDC) kanye ne-ticlopidine emsebenzini we-CYP1A2 kanye ne-caffeine metabolism: isifundo se-in vitro sokuqhathanisa ne-CDNA yomuntu esivezwe yi-CYP1A2 kanye nama-microsomes wesibindi. I-Pharmacol Rep. 2009; 61: 1216-1220. Buka okungaqondakali.
  104. Shet, M. S., McPhaul, M., Fisher, C. W., Stallings, N. R., no-Estabrook, R. W. Metabolism wesidakamizwa se-antiandrogenic (Flutamide) yi-CYP1A2 yabantu. Izidakamizwa zeMetab Yezidakamizwa. 1997; 25: 1298-1303. Buka okungaqondakali.
  105. IKynast-Gales SA, iMassey LK. Umphumela we-caffeine ekukhishweni kwe-circadian ye-urinary calcium ne-magnesium. J Am Coll Umsoco. 1994; 13: 467-72. Buka okungaqondakali.
  106. I-Spinella M. Herbal Medicines and Epilepsy: Okungenzeka Kuzuze Nemiphumela Emibi. Isifo sokuwa Behav 2001; 2: 524-532. Buka okungaqondakali.
  107. UMansi IA, uHuang J. Rhabdomyolysis ephendula umuthi wamakhambi wokwehlisa isisindo. NginguJ J Med Sci 2004; 327: 356-357. Buka okungaqondakali.
  108. USavitz DA, uChan RL, uHering AH, et al. Ingozi ye-caffeine nokukhulelwa kwesisu. I-Epidemiology 2008; 19: 55-62. Buka okungaqondakali.
  109. U-Weng X, u-Odouli R, u-Li DK. Ukusetshenziswa kwe-caffeine komama ngesikhathi sokukhulelwa kanye nengozi yokuphuphuma kwesisu: isifundo seqembu esizayo. NginguJ J Obstet Gynecol 2008; 198: 279.e1-8. Buka okungaqondakali.
  110. URobinson LE, uSavani S, uBattram DS, et al. Ukungeniswa kwe-caffeine ngaphambi kokuhlolwa kokubekezelelana ngomlomo ngomlomo kuphazamisa ukuphathwa kweglucose egazini emadodeni ane-type 2 yesifo sikashukela. UJ Nutriti 2004; 134: 2528-33. Buka okungaqondakali.
  111. ILake CR, iRosenberg DB, iGallant S, et al. I-Phenylpropanolamine inyusa amazinga e-plasma caffeine. I-Clin Pharmacol Ther 1990; 47: 675-85. Buka okungaqondakali.
  112. I-Forrest WH Jr, iBellville JW, uBrown BW Jr. Ukusebenzisana kwe-caffeine ne-pentobarbital njenge-hypnotic yasebusuku. I-Anesthesiology 1972; 36: 37-41. Buka okungaqondakali.
  113. URaaska K, uRaitasuo V, uLaitila J, uNeuvonen PJ. Imiphumela yekhofi equkethe i-caffeine uma iqhathaniswa ne-decaffeinated on concentrations ye-serum clozapine ezigulini ezibhedlela. I-Basic Clin Pharmacol Toxicol 2004; 94: 13-8. Buka okungaqondakali.
  114. UWatson JM, uSherwin RS, uDeary IJ, et al. Ukuhlukaniswa kwempendulo engathandwayo yomzimba, yehomoni nokuqonda kwi-hypoglycaemia ngokusetshenziswa okuqhubekayo kwe-caffeine. I-Clin Sci (Lond) 2003; 104: 447-54. Buka okungaqondakali.
  115. I-Winkelmayer WC, iStampfer MJ, iWillett WC, iCurhan GC. Ukudla okuvamile kwe-caffeine kanye nengozi yomfutho wegazi ophezulu kwabesifazane. I-JAMA 2005; 294: 2330-5. Buka okungaqondakali.
  116. UJuliano LM, uGriffiths RR. Ukubuyekezwa okubucayi kokuhoxiswa kwe-caffeine: ukuqinisekiswa kwezimpawu nezimpawu, izehlakalo, ubunzima, nezici ezihambisanayo. I-Psychopharmacology (Berl) 2004; 176: 1-29. Buka okungaqondakali.
  117. ULeson CL, McGuigan MA, uBryson SM. Ukudlula ngokweqile kwe-caffeine kowesilisa osemusha. UJ Toxicol Clin Toxicol 1988; 26: 407-15. Buka okungaqondakali.
  118. UBenowitz NL, u-Osterloh J, uGoldschlager N, et al. Ukukhishwa okukhulu kwe-catecholamine kusuka kubuthi be-caffeine. I-JAMA 1982; 248: 1097-8. Buka okungaqondakali.
  119. U-Acheson KJ, uGremaud G, Meirim I, et al. Imiphumela ye-Metabolic ye-caffeine ebantwini: i-lipid oxidation noma ibhayisekili eliyize? Ngingu-J J Nutriti 2004; 79: 40-6. Buka okungaqondakali.
  120. IHallerle CA, uBenowitz NL, uJacob P 3rd. Imiphumela ye-Hemodynamic ye-ephedra-free weight-supplements supplements kubantu. U-Am J Med 2005; 118: 998-1003 .. Buka okungaqondakali.
  121. UPetrie HJ, Chown SE, uBelfie LM, et al. Ukungeniswa kwe-caffeine kwandisa impendulo ye-insulin ekuhlolweni kokubekezela ngomlomo noshukela emadodeni akhuluphele ngaphambi nangemva kokulahleka kwesisindo. Ngingu-J J Nutriti 2004; 80: 22-8. Buka okungaqondakali.
  122. ILane JD, iBarkauskas CE, iSurwit RS, iFeinglos MN. I-caffeine iphazamisa i-glucose metabolism kuhlobo 2 lwesifo sikashukela. Ukunakekelwa yisifo sikashukela 2004; 27: 2047-8. Buka okungaqondakali.
  123. U-Andersen T, Fogh J. Ukwehla kwesisindo nokubambezeleka kokuqedwa kwesisu kulandela ukulungiswa kwamakhambi aseNingizimu Melika ezigulini ezikhuluphele. Ukudla kukaJ Hum Nutr 2001; 14: 243-50. Buka okungaqondakali.
  124. ICannon ME, iCooke CT, iMcCarthy JS. I-cardiac arrhythmia eyenziwe nge-caffeine: ingozi engaziwa yemikhiqizo yokudla yezempilo. IMed J Aust 2001; 174: 520-1. Buka okungaqondakali.
  125. UDews PB, O'Brien CP, uBergman J. Caffeine: imiphumela yokuziphatha yokuhoxa nezinkinga ezihlobene. Ukudla Chem Toxicol 2002; 40: 1257-61. Buka okungaqondakali.
  126. UHolmgren P, uNorden-Pettersson L, u-Ahlner J. Caffeine oshonile - imibiko yamacala amane. I-Forensic Sci Int 2004; 139: 71-3. Buka okungaqondakali.
  127. UChou T. Vuka uzwe iphunga lekhofi. I-caffeine, ikhofi, kanye nemiphumela yezokwelapha. ENtshonalanga J Med 1992; 157: 544-53. Buka okungaqondakali.
  128. UHowell LL, uCoffin VL, uSpealman RD. Imiphumela yokuziphatha nokuziphatha kwama-xanthine kuma-primates angewona awabantu. I-Psychopharmacology (Berl) 1997; 129: 1-14. Buka okungaqondakali.
  129. Isikhungo Sezokwelapha. I-Caffeine Yokusimamiswa Kokusebenza Komsebenzi Wengqondo: Amafomula Wokusebenza Kwezempi. Washington, DC: National Academy Press, 2001. Itholakala ku: http://books.nap.edu/books/0309082587/html/index.html.
  130. UZheng XM, uWilliam RC. Amazinga e-serum caffeine ngemuva kokungavunyelwe kwamahora angama-24: imiphumela yomtholampilo ekucabangeni kwe-dipyridamole Tl myocardial perfusion. UJ Nucl Med Technol 2002; 30: 123-7. Buka okungaqondakali.
  131. U-Aqel RA, uZoghbi GJ, uTrimm JR, et al. Imiphumela ye-caffeine efakwa ngemithambo yegazi ku-intracoronary-ephethwe i-adenosine-indone coronary hemodynamics ezigulini ezinesifo semithambo yegazi. NginguJ J Cardiol 2004; 93: 343-6. Buka okungaqondakali.
  132. Underwood i-DA. Imiphi imishanguzo okufanele ibanjwe ngaphambi kokuhlolwa kwe-pharmacologic noma kokuvivinya umzimba? ICleve Clin J Med 2002; 69: 449-50. Buka okungaqondakali.
  133. USmith A. Imiphumela ye-caffeine ekuziphatheni komuntu. Ukudla Chem Toxicol 2002; 40: 1243-55. Buka okungaqondakali.
  134. UStanek EJ, uMelko GP, uCharland SL. Ukuphazamiseka kweXanthine ne-dipyridamole-thallium-201 imaging myocardial. Ikhemisi 1995; 29: 425-7. Buka okungaqondakali.
  135. UCarrillo JA, uBenitez J.Ukuxhumana okuphawulekayo kwemithi phakathi kokudla okune-caffeine nemithi. Umtholampilo Pharmacokinet 2000; 39: 127-53. Buka okungaqondakali.
  136. I-Wahllander A, i-Paumgartner G. Umphumela we-ketoconazole ne-terbinafine kuma-pharmacokinetics we-caffeine kumavolontiya anempilo. I-Eur J Clin Pharmacol 1989; 37: 279-83. Buka okungaqondakali.
  137. USanderink GJ, uBournique B, uStevens J, et al. Ukubandakanywa kwama-isoenzymes we-CYP1A womuntu ekuxhumaneni kwe-metabolism kanye nezidakamizwa ze-riluzole in vitro. I-Pharmacol Exp Ther 1997; 282: 1465-72. Buka okungaqondakali.
  138. UBrown NJ, uRyder D, uGatsha RA. Ukusebenzisana kwe-pharmacodynamic phakathi kwe-caffeine ne-phenylpropanolamine. I-Clin Pharmacol Ther 1991; 50: 363-71. Buka okungaqondakali.
  139. U-Abernethy DR, Todd EL.Ukukhubazeka kokuvunyelwa kwe-caffeine ngokusetshenziswa okungapheli kwezindlela zokuvimbela inzalo zomlomo ezinomthamo ophansi. I-Eur J Clin Pharmacol 1985; 28: 425-8. Buka okungaqondakali.
  140. UMay DC, uJarboe CH, uVanBakel AB, uWilliam WM. Imiphumela ye-cimetidine esimweni se-caffeine kubantu ababhemayo nabangabhemi. I-Clin Pharmacol Ther 1982; 31: 656-61. Buka okungaqondakali.
  141. UNawrot P, Jordan S, Eastwood J, et al. Imiphumela ye-caffeine empilweni yomuntu. I-Addit Contam yokudla 2003; 20: 1-30. Buka okungaqondakali.
  142. UMassey LK, uWhiting SJ. I-caffeine, i-calcium yomchamo, i-calcium metabolism kanye nethambo. UJ Nutriti 1993; 123: 1611-4. Buka okungaqondakali.
  143. I-Infante S, iBaeza ML, iCalvo M, et al. I-Anaphylaxis ngenxa ye-caffeine. Ukungezwani komzimba 2003; 58: 681-2. Buka okungaqondakali.
  144. UNix D, uZelenitsky S, uSymonds W, et al. Umphumela we-fluconazole kuma-pharmacokinetics we-caffeine ezifundweni ezincane nezindala. I-Clin Pharmacol Ther 1992; 51: 183.
  145. I-Schechter MD, ama-Timmons GD. Kukalwe ngokungenhloso ukungasebenzi kahle - II. Imiphumela ye-Caffeine ne-amphetamine. J Clin Pharmacol 1985; 25: 276-80 .. Buka okungaqondakali.
  146. UKockler DR, uMcCarthy MW, uLawson CL. Umsebenzi wokubamba nokungaphenduli ngemuva kokungeniswa kwe-hydroxycut. I-Pharmacotherapy 2001; 21: 647-51 .. Buka okungaqondakali.
  147. IGrandjean AC, iReimers KJ, iBannick KE, iHaven MC. Umphumela weziphuzo ezine-caffeine, ezingenayo i-caffeine, i-caloric kanye ne-non-caloric ku-hydration. J Am Coll Nutriti 2000; 19: 591-600 .. Buka okungaqondakali.
  148. UKamimori GH, uPenetar DM, uHeadley DB, et al. Imiphumela yamanani amathathu e-caffeine kuma-catecholamine e-plasma nokuqapha ngesikhathi sokuvuka isikhathi eside. I-Eur J Clin Pharmacol 2000; 56: 537-44 .. Buka okungaqondakali.
  149. UDreher HM. Umphumela wokwehliswa kwe-caffeine kwikhwalithi yokulala nenhlalakahle kubantu abane-HIV. J Psychosom Res 2003; 54: 191-8 .. Buka okungaqondakali.
  150. IMassey LK. Ingabe i-caffeine iyingozi ekulahlekelweni kwethambo kubantu asebekhulile? Ngingu-J J Clin Nutr 2001; 74: 569-70. Buka okungaqondakali.
  151. UChen JF, uXu K, uPetzer JP, et al. I-Neuroprotection yi-caffeine ne-A (2A) adenosine receptor inactivation kwimodeli yesifo sikaParkinson. J Neurosci 2001; 21: RC143 .. Buka okungaqondakali.
  152. UNehlig A, uDebry G. Imiphumela enganeni esanda kuzalwa yokuphuza ikhofi komama ngesikhathi sokukhulelwa kanye nokuncelisa: ukubuyekeza. J Am Coll Nutriti 1994; 13: 6-21 .. Buka okungaqondakali.
  153. UMcGowan JD, Altman RE, Kanto WP Jr.Izimpawu zokuhoxa kweNonatal ngemuva kokungeniswa okungapheli komama nge-caffeine. ISouth Med J 1988; 81: 1092-4 .. Buka okungaqondakali.
  154. IBara AI, iBarley EA. I-caffeine yesifuba somoya. ICochrane Database Syst Rev 2001; 4: CD001112 .. Buka okungaqondakali.
  155. I-Bracken MB, iTriche EW, uBelanger K, et al. Inhlangano yokusetshenziswa kwe-caffeine komama ngokuncipha ekukhuleni kwengane. Ngingu-J Epidemiol 2003; 157: 456-66 .. Buka okungaqondakali.
  156. UHorner NK, uLampe JW. Izindlela ezingaba khona zokwelashwa kokudla kwezimo zesifuba se-fibrocystic zibonisa ubufakazi obanele bokusebenza. J Am Diet Assoc 2000; 100: 1368-80. Buka okungaqondakali.
  157. UBell DG, uJacobs I, u-Ellerington K. Umphumela we-caffeine ne-ephedrine ukungenisa ekusebenzeni kokuzivocavoca kwe-anaerobic. IMed Sci Sports Exerc 2001; 33: 1399-403. Buka okungaqondakali.
  158. IGreenway FL, uRaum WJ, uDeLany JP. Umphumela wesengezo sokudla esinamakhambi esiqukethe i-ephedrine ne-caffeine ekusetshenzisweni komoya-mpilo kubantu. J Altern Complement Med 2000; 6: 553-5. Buka okungaqondakali.
  159. IHallerle CA, uJacob P 3rd, uBenowitz NL. I-Pharmacology ye-ephedra alkaloids ne-caffeine ngemuva kokusetshenziswa komthamo owodwa wokudla okungeziwe. I-Clin Pharmacol Ther 2002; 71: 421-32. Buka okungaqondakali.
  160. I-Avisar R, i-Avisar E, i-Weinberger D. Umphumela wokusetshenziswa kwekhofi ekucindezelekeni kwe-intraocular. I-Ann Pharmacother 2002; 36: 992-5 .. Buka okungaqondakali.
  161. UFerrini RL, uBarrett-Connor E.Ukudla kwe-Caffeine namazinga we-sexo angapheli kwabesifazane be-postmenopausal. Isifundo seRancho Bernardo. Ngingu-J Epidemiol 1996: 144: 642-4. Buka okungaqondakali.
  162. U-Ardlie NG, uGlew G, uSchultz BG, uSchwartz CJ. Ukuvimbela nokubuyisa ukuhlanganiswa kweplatelet ngama-methyl xanthines. UTromb Diath Haemorrh 1967; 18: 670-3. Buka okungaqondakali.
  163. U-Ali M, u-Afzal M. I-inhibitor enamandla ye-thrombin evuselele ukwakheka kweplatelet thromboxane kusuka etiyeni elingasetshenziswanga. AmaProstaglandins Leukot Med 1987; 27: 9-13. Buka okungaqondakali.
  164. IHallerle CA, uBenowitz NL. Imicimbi emibi yenhliziyo nemithambo yegazi ehambisana nezithako zokudla eziqukethe i-ephedra alkaloids. N Engl J Med 2000; 343: 1833-8. Buka okungaqondakali.
  165. USuleman A, uSiddiqui NH. Imiphumela ye-haemodynamic nenhliziyo ye-caffeine. I-Medicine On Line Int J Medicine 2000. www.priory.com/pharmol/caffeine.htm (Kufinyelelwe ngomhla ka-14 Ephreli 2000).
  166. USinclair CJ, uGiiger JD. Ukusetshenziswa kwe-caffeine kwezemidlalo. Ukubuyekezwa kwemithi. J Ezemidlalo Med Fitness 2000; 40: 71-9. Buka okungaqondakali.
  167. UBourin M, uBougerol T, uGuitton B, uBroutin E. Inhlanganisela yezitshalo ezitshalwayo ekwelapheni iziguli eziphuma ngaphandle ezinezinkinga zokulungisa ezinokukhathazeka: isifundo esilawulwayo vs i-placebo. I-Fundam Clin Pharmacol 1997; 11: 127-32. Buka okungaqondakali.
  168. I-American Academy Yezingane. Ukudluliswa kwezidakamizwa namanye amakhemikhali obisini lomuntu. Izifo zezingane 2001; 108: 776-89. Buka okungaqondakali.
  169. ULloyd T, uJohnson-Rollings N, u-Eggli DF, et al. Isimo samathambo phakathi kwabesifazane be-postmenopausal abanokudla okuhlukile kwe-caffeine: uphenyo olude. UJ Am Coll Nutriti 2000; 19: 256-61. Buka okungaqondakali.
  170. UWatson JM, uJenkins EJ, uHamilton P, et al. Ithonya le-caffeine kumvamisa nasekuboneni kwe-hypoglycemia ezigulini eziphila mahhala ezinesifo sikashukela sohlobo 1. Ukunakekelwa yisifo sikashukela 2000; 23: 455-9. Buka okungaqondakali.
  171. UTobias JD. I-caffeine ekwelapheni i-apnea ehlotshaniswa nokutheleleka ngegciwane le-syncytial virus kuma-neonates nasezinsaneni. ISouth Med J 2000; 93: 297-304. Buka okungaqondakali.
  172. URoss GW, Abbott RD, uPetrovitch H, et al. Ukuhlangana kwekhofi kanye ne-caffeine engozini yesifo se-parkinson. I-JAMA 2000; 283: 2674-9. Buka okungaqondakali.
  173. UHagg S, Spigset O, Mjorndal T, Dahlqvist R. Umphumela we-caffeine kuma-pharmacokinetics e-clozapine kumavolontiya anempilo. UBr J Clin Pharmacol 2000; 49: 59-63. Buka okungaqondakali.
  174. Ikhodi ye-elekthronikhi yemithethonqubo kahulumeni. Isihloko 21. Ingxenye 182 - Izinto Ngokuvamile Zaziwa Njengokuphepha. Kutholakala ku: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  175. UWilliam MH, uGatsha JD. Dala ukwengeza nokusebenza kokuzivocavoca: isibuyekezo. UJ Am Coll Nutriti 1998; 17: 216-34. Buka okungaqondakali.
  176. AmaBriggs GB, uFreeman RK, uYaffe SJ. Izidakamizwa Ekukhulelweni naseLactation. Umhlaka 5. IPhiladelphia, PA: Lippincott Williams & Wilkins; 1998.
  177. UBoozer CN, uNasser JA, uHeymsfield SB, et al. Isengezo semithi esineMa Huang-Guarana yokwehlisa isisindo: isilingo esingahleliwe, esiyimpumputhe. I-Int J Obes Relat Metab Disord 2001; 25: 316-24. Buka okungaqondakali.
  178. I-FDA. Umthetho ophakanyisiwe: izithako zokudla eziqukethe i-ephedrine alkaloids. Itholakala ku: www.verity.fda.gov (Ifinyelelwe ngomhla ka-25 Januwari 2000).
  179. UDews PB, uC Curtis GL, uHanford KJ, u-O'Brien CP. Ukuvama kokuhoxa kwe-caffeine kunhlolovo esekwe kubantu nasekuhlolweni okulawulwayo, okuyimpumputhe. UJ Clin Pharmacol 1999; 39: 1221-32. Buka okungaqondakali.
  180. UNurminen ML, Niittynen L, Korpela R, Vapaatalo H. Ikhofi, i-caffeine nomfutho wegazi: ukubuyekeza okubucayi. I-Eur J Clin Nutr 1999; 53: 831-9. Buka okungaqondakali.
  181. Rees K, Allen D, Lader M. Amathonya weminyaka ne-caffeine ku-psychomotor nokusebenza kwengqondo. I-Psychopharmacology (Berl) 1999; 145: 181-8. Buka okungaqondakali.
  182. UDiPiro JT, uTalbert RL, Yee GC, et al; ama-eds. I-Pharmacotherapy: Indlela ye-pathophysiologic. Umhla wesi-4. IStamford, CT: I-Appleton neLange, 1999.
  183. UPollock BG, uWylie M, uStack JA, et al. Ukuvinjelwa kwe-caffeine metabolism nge-estrogen therapy esikhundleni sabesifazane be-postmenopausal. UJ Clin Pharmacol 1999; 39: 936-40. Buka okungaqondakali.
  184. I-Wemple RD, iWundlu DR, uMcKeever KH. I-caffeine vs iziphuzo zemidlalo ezingenayo i-caffeine: imiphumela ekukhiqizeni umchamo ngesikhathi sokuphumula nangesikhathi sokuzivocavoca isikhathi eside. I-Int J Sports Med 1997; 18: 40-6. Buka okungaqondakali.
  185. IStookey JD. Imiphumela yokuchama yotshwala ne-caffeine kanye nokuhlanjululwa kwamanzi okuphelele. I-Eur J Epidemiol 1999; 15: 181-8. Buka okungaqondakali.
  186. UFernandes O, Sabharwal M, uSmiley T, et al. Ukusetshenziswa okulingene kuya okusindayo kwe-caffeine ngesikhathi sokukhulelwa nobudlelwano nokukhipha isisu okuzenzekelayo nokukhula okungavamile kombungu: ukuhlaziywa kwe-meta. I-Reprod Toxicol 1998; 12: 435-44. Buka okungaqondakali.
  187. U-Eskenazi B. Caffeine-ukuhlunga amaqiniso. N Engl J Med 1999; 341: 1688-9. Buka okungaqondakali.
  188. UKlebanoff MA, uLevine RJ, uDerSimonian R, et al. I-maternal serum paraxanthine, i-caffeine metabolite, kanye nengozi yokukhipha isisu ngokuzenzekelayo. N Engl J Med 1999; 341: 1639-44. Buka okungaqondakali.
  189. Uhlelo Lukazwelonke Lwe-Toxicology (NTP). Ikhafeyini. Isikhungo Sokuhlolwa Kwezingozi Zokukhiqizwa Komuntu (CERHR). Itholakala ku: http://cerhr.niehs.nih.gov/common/caffeine.html.
  190. URapuri PB, uGallagher JC, uKinyamu HK, uRyschon KL. Ukudla kwe-caffeine kukhuphula izinga lokulahleka kwamathambo kwabesifazane asebekhulile futhi kuhlangana ne-vitamin D receptor genotypes. Ngingu-J J Clin Nutr 2001; 74: 694-700. Buka okungaqondakali.
  191. I-Chiu KM. Ukusebenza kwe-calcium supplements ku-bone mass kwabesifazane be-postmenopausal. UJ Gerontol A Biol Sci Med Sci 1999; 54: M275-80. Buka okungaqondakali.
  192. UVandeberghe K, Gillis N, Van Leemputte M, et al. I-caffeine iphikisana nesenzo se-ergogenic sokulayisha kwemisipha ye-muscle. UJ Appl Physiol 1996; 80: 452-7. Buka okungaqondakali.
  193. Ukuchazwa Kwezilingo Zokuxilonga. Amazwibela weLaboratory Medicine. Okwesihlanu ed; IBoston, MA: Little Brown, 1992.
  194. UHodgson JM, uPuddey IB, uBurke V, et al. Imiphumela yengcindezi yegazi yokuphuza itiye eliluhlaza nokumnyama. UJ Hypertens 1999; 17: 457-63. Buka okungaqondakali.
  195. Wakabayashi K, Kono S, Shinchi K, et al. Ukusetshenziswa kwekhofi ejwayelekile nokucindezelwa kwegazi: Ucwaningo lwezikhulu zokuzivikela eJapan. I-Eur J Epidemiol 1998; 14: 669-73. Buka okungaqondakali.
  196. Okwe-Dieter, Cishe Ukulahlekelwa Kokugcina. IWashington Post. Kutholakala ku: http://www.washingtonpost.com/archive/politics/2000/03/19/for-dieter-nearly-the-ultimate-loss/c0f07474-489d-4f44-bc17-1f1367c956ae/ (Kufinyelelwe ngo-19 Mashi 2000 ).
  197. UVahedi K, uDomingo V, u-Amarenco P, uBousser MG. Ukushaywa yischemic kumuntu wezemidlalo odle okukhishwe uMaHuang futhi wakha i-monohydrate yokwakha umzimba. UJ Neurol Neurosurg Psychiatr 2000; 68: 112-3. Buka okungaqondakali.
  198. UJoeres R, uKlinker H, uHeusler H, et al. Ithonya le-mexiletine ekususweni kwe-caffeine. I-Pharmacol Ther 1987; 33: 163-9. Buka okungaqondakali.
  199. UBreum L, uPedersen JK, u-Ahlstrom F, et al. Ukuqhathaniswa kwenhlanganisela ye-ephedrine / caffeine kanye ne-dexfenfluramine ekwelapheni ukukhuluphala. Isivivinyo sezikhungo eziningi ezingaboni kahle ngokujwayelekile. I-Int J Obes Relat Metab Disord 1994; 18: 99-103. Buka okungaqondakali.
  200. UJefferson JW. Ukuthuthumela kweLithium kanye nokudla kwe-caffeine: amacala amabili okuphuza kancane nokuthuthumela ngaphezulu. J Clin Psychiatry 1988; 49: 72-3. Buka okungaqondakali.
  201. UMester R, uToren P, uMizrachi I, et al. Ukuhoxa kwe-caffeine kwandisa amazinga egazi e-lithium. I-Biol Psychiatry 1995; 37: 348-50. Buka okungaqondakali.
  202. UHealy DP, uPolk RE, uKanawati L, et al. Ukusebenzisana phakathi komlomo we-ciprofloxacin ne-caffeine kumavolontiya ajwayelekile. Ama-Antimicrob Agents Chemother 1989; 33: 474-8. Buka okungaqondakali.
  203. UCarbo M, uSegura J, uDe la Torre R, et al. Umphumela wama-quinolone esimweni se-caffeine. I-Clin Pharmacol Ther 1989; 45: 234-40. Buka okungaqondakali.
  204. I-Harder S, i-Fuhr U, i-Staib AH, i-Wolff T. Ciprofloxacin-caffeine: ukuxhumana kwezidakamizwa okusungulwe kusetshenziswa uphenyo lwe-vivo kanye ne-in vitro. NginguJ Med 1989; 87: 89S-91S. Buka okungaqondakali.
  205. UMcEvoy GK, umhleli. Imininingwane Yezidakamizwa ze-AHFS. I-Bethesda, MD: I-American Society of Health-System Pharmacists, ngo-1998.
  206. UMcGuffin M, uHobbs C, u-Upton R, uGoldberg A, ama-eds. Ibhuku le-American Herbal Products Association's Botanical Safety Handbook. IBoca Raton, FL: CRC Press, LLC 1997.
  207. USchulz V, uHansel R, uTyler VE. I-Rational Phytotherapy: Umhlahlandlela Wodokotela Emithini Yezokwelapha. Terry C. Telger, ukuhumusha 3rd ed. IBerlin, iGER: Springer, 1998.
Kugcine ukubuyekezwa - 01/05/2021

-Nconyisile

I-Turmeric Yesikhumba: Izinzuzo Nezingozi
Impilo

I-Turmeric Yesikhumba: Izinzuzo Nezingozi

ifaka imikhiqizo e icabanga ukuthi ilu izo kubafundi bethu. Uma uthenga ngezixhumani i ezikuleli kha i, ingathola ikhomi hini encane. Nan i inqubo yethu. I iphepho ekungamakhulu eminyaka, abantu emhl...
I-Laparoscopy
Impilo

I-Laparoscopy

Kuyini i-laparo copy?I-laparo copy, eyaziwa nangokuthi i-laparo copy yokuxilonga, inqubo yokuhlinza yokuhlonza e et henzi elwa ukuhlola izitho ngaphakathi kwe i u. Kuyindlela enobungozi obuphan i, in...